NEAL CONAN, host: Last month, the Food and Drug Administration announced the approval of two new drugs for the treatment of hepatitis C virus type 1, the first major advance in treatment in years. The good news: the new drugs can leave patients apparently free of the virus. The bad news: according to the Centers for Disease Control and Prevention, as many as three out of four Americans with hep C don't know they're infected and don't seek treatment. Of the over three million Americans infected with hepatitis C, two-thirds are baby boomers, and the CDC may recommend screening for everyone aged 45 to 64.
.
From
NPR -
New Drugs Offer Hope For Hepatitis C Sufferers
Or read the
transcript
Dr. JOHN WARD: Thank you, Neal. Good afternoon.
CONAN: And congratulations, I guess.
WARD: Yes. This is just a great advance for hepatitis C treatment and increased opportunities for hope and for clearing the virus among the 3.2 million persons living with this infection in the United States.
CONAN: What's different about these drugs?...........
continue reading..........
.
No comments:
Post a Comment